Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,443 | N/A | 277,200 | 365,700 | 218,300 |
| Receivables | N/A | N/A | 427,000 | 453,000 | 385,800 |
| Inventories | N/A | N/A | 1,843,300 | 1,763,000 | 1,551,500 |
| Other current assets | 0 | 0 | 342,600 | 320,900 | 278,800 |
| TOTAL | $148,275 | $N/A | $2,890,100 | $2,902,600 | $2,434,400 |
| Non-Current Assets | |||||
| PPE Net | 16,944 | N/A | 815,700 | 787,900 | 729,700 |
| Investments And Advances | 0 | 0 | 57,300 | 51,500 | 42,200 |
| Intangibles | 0 | 0 | 4,782,200 | 4,879,100 | 4,202,900 |
| Other Non-Current Assets | 1,793 | 0 | 39,400 | 55,000 | 82,600 |
| TOTAL | $18,737 | $N/A | $5,694,600 | $5,773,500 | $5,057,400 |
| Total Assets | $167,012 | $N/A | $8,584,700 | $8,676,100 | $7,491,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,101 | 0 | 241,700 | 264,000 | 206,100 |
| Accrued Expenses | 1,734 | N/A | N/A | N/A | N/A |
| Other current liabilities | 2,752 | N/A | 452,100 | 506,600 | 524,200 |
| TOTAL | $25,587 | $N/A | $706,600 | $1,250,700 | $758,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,024,500 | 2,024,900 | 1,902,100 |
| Other Non-Current Liabilities | 258,831 | 0 | 252,800 | 338,300 | 352,100 |
| TOTAL | $258,831 | $N/A | $2,804,000 | $2,816,200 | $2,633,400 |
| Total Liabilities | $284,418 | $N/A | $3,510,600 | $4,066,900 | $3,392,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 165,336 | 160,327 | 156,721 |
| Common Shares | 56 | N/A | 734,000 | 734,000 | 734,000 |
| Retained earnings | -124,718 | N/A | 6,352,600 | 6,136,800 | 5,892,600 |
| Other shareholders' equity | 0 | 0 | -146,700 | -186,300 | -299,300 |
| TOTAL | $-117,406 | $N/A | $5,074,100 | $4,609,200 | $4,099,700 |
| Total Liabilities And Equity | $167,012 | $0 | $8,584,700 | $8,676,100 | $7,491,800 |